Next Article in Journal
Facile Enhancement of Mechanical Interfacial Strength of Recycled Carbon Fiber Web-Reinforced Polypropylene Composites via a Single-Step Silane Modification Process
Previous Article in Journal
Wild-Grown Romanian Eupatorium cannabinum: Advancing Phyto-Nanocarriers via Maltodextrin Micro-Spray Encapsulation—Metabolite Profiling, Antioxidant, Antimicrobial, and Cytotoxicity Insights
Previous Article in Special Issue
Evaluation of Mechanical Properties of Composite Material with a Thermoplastic Matrix Reinforced with Cellulose Acetate Microfibers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Polymers
Volume 17
Issue 4
10.3390/polym17040484
polymers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of Curcumin-Loaded TiO2-Reinforced Chitosan Monofilaments for Biocompatible Surgical Sutures

by
Fatma Demirci
Department of Polymer Materials Engineering, Faculty of Engineering and Natural Sciences, Bursa Technical University, 16310 Bursa, Türkiye
Polymers 2025, 17(4), 484; https://doi.org/10.3390/polym17040484
Submission received: 15 January 2025 / Revised: 7 February 2025 / Accepted: 11 February 2025 / Published: 12 February 2025
(This article belongs to the Special Issue Preparation and Application of Cellulose-Based and Chitosan-Based Materials)
Browse Figures
Versions Notes

Abstract

:
Sutures provide mechanical support for wound closure after various traumas and surgical operations. Absorbable sutures are increasingly favored as they eliminate the need for secondary procedures and minimize additional damage to the wound site. In this study, chitosan sutures were produced using the dry jet–wet spinning method, achieving number 7-0 sutures (approximately 76 μm diameter) with a homogeneous surface. FTIR analysis demonstrated molecular interactions between chitosan and TiO2 or curcumin, confirming successful incorporation. The addition of 3% TiO2 increased the tensile strength of chitosan sutures by 12.32%, reaching 189.41 MPa. Morphological analysis revealed smooth surfaces free of pores and bubbles, confirming the production of high-quality sutures. Radical scavenging activity analysis showed that curcumin-loaded sutures exhibited 43% scavenging ability after 125 h, which was significantly higher compared to pure chitosan sutures. In vitro antibacterial tests demonstrated that curcumin-loaded sutures provided 98.87% bacterial inactivation against S. aureus within 24 h. Additionally, curcumin release analysis showed a cumulative release of 77% over 25 h. The bioactivity of the sutures was verified by hydroxyapatite layer formation after incubation in simulated body fluid, supporting their potential for tissue regeneration. These findings demonstrate that TiO2 reinforcement and curcumin loading significantly enhance the functional properties of chitosan sutures, making them strong candidates for biocompatible and absorbable surgical applications.

Graphical Abstract

1. Introduction

Various medical devices can be used to hold tissues together after trauma or surgery. Although significant advances have been made in tissue adhesives and other mechanical wound closure devices such as surgical staples and skin closure tapes, surgical sutures are still the most preferred method of wound closure in both human and veterinary medicine due to their easy accessibility and applicability [1,2]. Although not all of them will provide all the features, an ideal suture provides appropriate mechanical strength, causes minimal tissue damage and reaction, reduces the risk of infection, is easy to use, and is relatively inexpensive. Sutures that provide the necessary mechanical support to the wound during the healing period are preferred in many medical applications with their stated superior features and therefore the demand for sutures increases by millions of dollars every year [3]. Sutures can be classified in various categories depending on the material used (natural or synthetic), their degradability (absorbable or non-absorbable), and their physical configuration (monofilament, multifilament, twisted, or braided) [3,4].
The most basic features expected from a suture are that it reinforces the wound closure externally and is biocompatible to support wound healing [5,6]. These requirements vary depending on the type of wound and its location. For example, while tendons take weeks to heal, epithelial tissue and muscles can heal within a few days [3,7]. Although non-absorbable sutures generally have higher durability, they can cause complications such as chronic inflammation, infection, and tissue damage [6]. On the other hand, they need to be removed from the patient with a second operation. For all these reasons, the development of absorbable sutures is seen as an important development in the field of surgical sutures [2,3]. Absorbable surgical sutures can be produced from natural polymers such as catgut [8], collagen [9], and chitin [10] fibers or synthetic polymers such as polyglycolic acid [11], poly(p-dioxanone) [12], poly(lactic-co-glycolic acid) [13], poly(trimethylene carbonate) [14], and polycaprolactone [15]. Natural origin sutures stand out due to their properties such as antibacterial, antifungal, and preventing scar formation [4,16].
The limited solubility of chitin in both aqueous and organic solutions restricts its practical applications. However, chitosan, which is derived from chitin through deacetylation, offers improved solubility and is therefore more suitable for biological applications [17]. Due to its excellent biocompatibility [18], biodegradability [19], low toxicity [20], antimicrobial [21], antioxidant [22], and anticancer [23] properties, chitosan is widely regarded as a promising polymer for biomedical and pharmaceutical applications [24]. Despite these advantages, the low mechanical strength of chitosan-based sutures restricts their direct use in surgical applications. As a result, chitosan is predominantly applied as a coating material on commercial sutures. Nevertheless, recent studies have explored the direct production of sutures from chitosan, aiming to overcome its mechanical limitations while preserving its beneficial biological properties. Montenegro and Godeiro used QiGel® chitosan fibers being produced by Medovent GmbH as a suture material on rats and demonstrated the superiority of chitosan sutures by comparing their biodegradable and bacteriostatic properties with different sutures [25]. Silva et al. produced drug-loaded wet-spun chitosan sutures and investigated the morphological, biodegradation, drug release, mechanical, and cytotoxic properties of the produced sutures. It was stated that N-acetyl-D-glucosamine additive reduces mechanical performance but improves properties such as biodegradability, biocompatibility, and extended drug release of chitosan sutures, making them a good candidate for absorbable sutures [4]. Perrin et al. produced wet-spun chitosan sutures from high molecular weight fungal and shrimp chitosan and low molecular weight shrimp chitosan. They revealed the chosen chitosan and solvent effect on mechanical properties of the suture. They also examined the morphological properties and biocompatibility of the produced sutures [26]. Tan et al. prepared ultra-high molecular weight chitosan with different deacetylation degrees and molecular weights, and then produced chitosan sutures with a wet-spinning process. The effects of the deacetylation degree and molecular weight of chitosan on the morphological, mechanical, swelling degree, enzymatic degradation, and cytotoxic properties of the produced sutures were investigated [3].
As mentioned, although chitosan exhibits very good properties in terms of biomedical applications, the most important parameter limiting the industrialization of chitosan in suture applications is its low mechanical performance. To address this limitation, various additives such as nanoclay [27], carbon nanotubes [28], or inorganic nanoparticles [29] have been explored in the literature to enhance the mechanical properties of chitosan. Among these, TiO2 was selected as the sole additive in this study due to its well-documented ability to significantly improve both the mechanical strength and bioactivity of polymeric materials. TiO2 nanoparticles form covalent bonds with chitosan, leading to enhanced tensile properties without compromising biocompatibility. Additionally, TiO2 has demonstrated superior biocompatibility [30], bioactivity [31], and antimicrobial [30,31] potential in biomedical applications compared to other additives. While carbon nanotubes may pose cytotoxicity risks, nanoclay is primarily used as a carrier for bioactive agents rather than directly enhancing bioactivity. In contrast, TiO2 not only reinforces the mechanical properties of the suture but also actively contributes to its bioactive characteristics [32,33,34,35,36]. However, it should be noted that the effects of TiO2 can vary depending on factors such as particle size, concentration, and surface chemistry. In some cases, excessive TiO2 content has been reported to cause aggregation, leading to a reduction in mechanical performance, or to interfere with cellular interactions, affecting bioactivity negatively [37,38,39].
Curcumin is a phytopolyphenol obtained from the Curcuma longa plant [40]. This bioactive compound is a multifunctional active agent known with antibacterial [41], antifungal [42], antiviral [43], antioxidant [44], anti-inflammatory [44], anticoagulant [45], antiatherosclerotic [46], anticarcinogenic [47], and hypoglycemic [48] effects. Due to these therapeutic effects, it is preferred for use in pharmaceutical and biomedical fields.
This study demonstrates the production of chitosan sutures using the dry jet–wet spinning method, which has not been previously reported in the literature for chitosan-based surgical sutures. TiO2 was incorporated to enhance the mechanical strength of chitosan, addressing its limitations in suture applications. Once the desired mechanical properties were achieved, curcumin was added to improve the therapeutic potential of the sutures. The obtained sutures were characterized in terms of their morphological, physicochemical, and mechanical properties. Additionally, the effects of TiO2 and curcumin on radical scavenging activity, biocidal performance, and bioactivity were evaluated. The release profile of curcumin from the sutures was also examined to assess its potential for sustained therapeutic effects.

2. Materials and Methods

2.1. Materials

Chitosan (85% deacetylated) was supplied from Alfa Aesar (Karlshure, Germany) and acetic acid (99.8% purity) was purchased from Sigma-Aldrich (Steinheim, Germany). To prepare the coagulation bath, sodium hydroxide (NaOH) was acquired from Sigma-Aldrich (Prague, Czech Republic) and ethanol was obtained from Alkomed (Kocaeli, Türkiye). TiO2 in rutile phase used as additive material was synthesized by Duman and her team at Bursa Technical University Metallurgical Materials Engineering Laboratory. The TiO2 has 254.2 nm particle size, 18.9 m2/g surface area, and 4.22 g/cm3 density [49]. The other additive curcumin was obtained from Gemma (Kocaeli, Türkiye) in powder form. For radical scavenging activity tests, 2,2-Diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl (DPPH) was purchased from Sigma-Aldrich (Steinheim, Germany) and methanol was obtained from Merck (Darmstadt, Germany). Reagents to prepare the simulated body fluid (SBF) solution, sodium chloride (NaCl), potassium chloride (KCl), calcium chloride dihydrate (CaCl2·2H2O), magnesium chloride hexahydrate (MgCl2·6H2O), and sodium dihydrogen phosphate monohydrate (NaH2PO4·H2O), were purchased from Merck (Darmstadt, Germany) and sodium bicarbonate (NaHCO3) was obtained from Sigma-Aldrich (Steinheim, Germany). Phosphate-buffered saline (PBS, pH 7.4) was obtained from Gündüz Kimya™ (İstanbul, Türkiye). Tween 80 was acquired from KimyaLab (İstanbul, Türkiye).

2.2. Production of the Sutures

The dry jet–wet spinning process was used to produce chitosan sutures. Chitosan was dissolved in an acetic acid solution, taking into account both the required acid concentration and the degree of deacetylation, as referenced in Perrin et al. [26]. Based on literature studies, a 4% chitosan solution was selected for fiber spinning and dissolved in 0.239 mol/L acetic acid by stirring overnight at room temperature [4,26,50,51,52]. TiO2 was then added at concentrations of 1%, 3%, and 5% by weight of chitosan, and the solution was sonicated for 15 min to ensure homogeneous dispersion before being mixed overnight. For the production of curcumin-loaded sutures, 1% curcumin (by weight of chitosan) was added to the solution and mixed for 45 min at room temperature. Throughout the preparation of the suture spinning solutions, the total solids concentration was maintained at 4 wt%. The compositions of the spinning solutions of the produced sutures are given in Table 1.
Sutures were produced using a custom-made spinning unit. The prepared solutions were transferred to a 20 mL syringe and pumped into the coagulation bath at pH 13 (1:1 mL/mL; ethanol and 10% aqueous solution of NaOH) with a flowing rate of the solution of 2.5 mL/min using a syringe pump (IPS 12, Inovenso (İstanbul, Türkiye)). The fibers entered the coagulation bath after passing a 105 mm air gap, and passed through the washing bath by the help of a 61 mm diameter perforated drum. Then, the fibers were wrapped around a 620 mm diameter wheel and kept in the washing bath for approximately 1 h until the pH reached close to 7. Subsequently, the fibers were dried overnight at room temperature by stretching. While the chitosan suture produced without additives was called CS, the TiO2 added sutures were named CS/1T, CS/3T, and CS/5T depending on the additive ratio they contained. The suture produced by adding curcumin was named CS/3T/C.

2.3. Characterizaton of the Produced Sutures

The structure of the produced sutures and the effects of the TiO2 and curcumin addition were observed with Fourier-transform infrared spectroscopy (FTIR). FTIR spectra of the produced sutures were recorded by a PerkinElmer Spectrum Two spectrometer (Shelton, CT, USA) in the scanning range of 400 to 4000 cm−1 and 16 scans were made at 4 cm−1.
The surface morphology of the produced sutures was observed by field emission scanning electron microscopy (FE-SEM, Carl-Zeiss/Gemini 300 (Oberkochen, Germany)) before and after incubation in SBF. Ten nm gold palladium was coated on the surface of the suture samples and coated samples were imaged with 200× and 500× magnifications.
Mechanical properties of the produced sutures were determined by uniaxial tensile tests according to ASTM D2256 standard [53] with 2 mm/min strain rate, similar to previous research [4].
In vitro swelling behavior of the produced sutures was determined by the gravimetric method. The dry weights of the samples cut from the produced sutures were weighed (WD) and immersed in 5 mL of phosphate-buffered saline (PBS, pH 7.4, 37 °C) solution. After a 24 h incubation period, the samples were taken from solution and the wet weights of the samples (WW) were determined after the fluid on the sample surface was gently blotted. The swelling degrees (WS) of the samples for different incubation times were calculated using Equation (1):
(WS) = (WW − WD),
Radical scavenging activity (RSA) of the produced sutures was observed by the DPPH method. A 1 mM DPPH solution was prepared by dissolving 3.94 mg DPPH in 100 mL methanol. An amount of 20 mg of the produced sutures was placed in dark test tubes containing 4 mL of methanol and 0.5 mL of prepared methanolic DPPH solution was added to each tube and the samples were stored in a darkroom at room temperature. The absorbance of reaction solution was measured daily with a UV–Visible spectrophotometer (Scinco-NEOSYS200 (Taipei, Taiwan)) at 517 nm and the RSA% of samples was calculated using Equation (2):
RSA (%) = ((ADPPH − ASAMPLE)/ADPPH) × 100,
where ADPPH and ASAMPLE were the absorbance of the blank and reaction solutions, respectively.
To determine curcumin loading efficiency, a known amount of CS/3T/C suture sample and curcumin was dissolved in a 10.5 mL (10:10:1) ethanol/distilled water/acetic acid solution. The absorbance of the obtained solutions was measured with a UV–Visible spectrophotometer (Scinco-NEOSYS200) at 431 nm and the loading efficiency (LE%) was calculated using Equation (3):
LE (%) = ((mC × ACS/3T/C)/(mCS/3T/C × AC)) × 100,
where mC and mCS/3T/C were the weight of the curcumin and curcumin-loaded suture sample dissolved in ethanol/distilled water/acetic acid solution, and AC and ACS/3T/C were the absorbance of the curcumin and curcumin-loaded suture sample solutions, respectively.
For curcumin release analysis, firstly the amount of curcumin in 10 mg suture was calculated according to the value obtained from the LE result and accordingly the calibration curve was obtained by determining the total curcumin ratio in the suture. In order to determine the curcumin release, 10 mg of CS/3T/C sample was immersed in 10 mL of PBS solution containing 5% Tween 80 for 48 h at 37 °C. Since curcumin was insoluble in pure PBS solution, Tween 80 was added to the solution to dissolve free-released curcumin. Samples were taken in solution at different times and measurements were taken with a UV–Visible spectrophotometer at 431 nm. The experiment was performed in triplicate.
The in vitro bioactivity of the produced sutures (CS, CS/3T, CS/3T/C) was determined by immersion in 10 × SBF (adjusted at pH 7.4 with NaHCO3) which contains 10 times the calcium and phosphate ion concentrations of human plasma and being prepared according to a previous study [54]. After 3 and 14 days of incubation in 10 × SBF, the suture samples were removed from the solution, gently washed with deionized water, and dried at 37 °C. After the incubation period, the surface morphology of the sutures was observed by SEM. The Ca/P ratio of the mineralized layer of the CS/3T/C sample was analyzed using an Energy Dispersive X-ray Spectrometer (EDS, Bruker™ XFlash 6I100 (Berlin, Germany)). The chemical composition of the HA layer on the CS/3T/C suture was determined by FTIR analysis.
Biocidal efficacy performance of the produced sutures was determined under dynamic contact conditions according to ASTM E2149. The suture samples were tested against Staphylococcus aureus (ATCC 6538) and Escherichia coli (ATCC 35218). Briefly, for antibacterial activity evaluation, 2.5 mg suture samples were placed in 2 mL known concentration bacterial suspension (approximately 5 × 105 CFU/mL) and shaken. For 3, 6, and 24 h contact times, 100 µL of bacterial suspensions were taken and diluted with phosphate-buffered solution. The diluted solutions were spread onto Mueller-Hilton II agar media and incubated for 24 h at 37 °C. At the end of the incubation period, viable bacterial colonies were counted and the inhibition percentage (%) was calculated using Equation (4):
Reduction rate of bacteria (%) = ((A − B)/A) × 100,
where A is the number of bacteria recovered from the test sample at “0” contact time, and B is the number of bacteria recovered from test samples incubated for specific periods of time, respectively.

3. Results and Discussion

3.1. Influence of the TiO2 Addition on the Mechanical Properties of the Sutures

The mechanical performance of the suture is of great importance both in terms of ease of operation and keeping the wound closed until tissue regeneration after application. Despite its advantages such as biocompatibility, non-toxicity, and biodegradability, chitosan is studied in the literature as a coating on sutures rather than direct suture applications due to its low mechanical properties [1]. In recent years, studies have been carried out on the production of chitosan sutures with improved mechanical strength and functional properties [4,26]. As known in the literature, TiO2 nanoparticles transform into titanium cation (Ti4+) in an acidic environment and form covalent bonds with –OH and –NH2 groups of the chitosan [55]. In the first part of this study, TiO2 was added to the chitosan suture in order to increase its mechanical properties. TiO2 addition effects on the mechanical properties of the sutures are given in Table 2. The tensile strength of the CS suture was 168.63 MPa and the addition of 1 wt% and 3 wt% TiO2 nanoparticles to the suture structure caused an increase in both tensile strength and elongation at break. This increase could be related to the molecular interaction between the TiO2 nanoparticles and chitosan [55]. As seen in Table 2, the tensile strength of the CS/3T suture reached 189.41 MPa, demonstrating a 12.32% improvement compared to the unmodified CS suture. However, when the TiO2 content increased to 5 wt%, the tensile strength dropped to 148.83 MPa, which is lower than the CS suture. Similar trends have been observed in previous studies, where excessive TiO2 addition to chitosan-based films led to aggregation, reducing mechanical performance [38,39].
According to the United States Pharmacopeia (USP) standards, the minimum breaking force required for 7-0 surgical sutures is 0.785 N. The breaking strength of the CS suture was measured as 0.74 N, which is slightly below the USP requirement. However, with the addition of 1 wt% and 3 wt% TiO2, the breaking strength increased to 0.77 N and 0.84 N, respectively, surpassing the USP standard. This indicates that the CS/3T suture meets the mechanical strength criteria defined for 7-0 surgical sutures, making it a viable candidate for clinical applications. Conversely, the CS/5T suture exhibited a breaking strength of 0.66 N, which is lower than the USP requirement. This decrease in mechanical strength can be attributed to TiO2 nanoparticle agglomeration, which disrupted the polymer network and reduced overall tensile performance.
In addition to tensile strength, elongation at break plays a critical role in the mechanical behavior and functional performance of surgical sutures. Sutures need to retain a degree of flexibility to accommodate tissue swelling and contraction during the healing process. When swelling occurs, the suture should stretch to prevent excessive tension on the wound and when the swelling subsides, the suture should return to its original shape and length to maintain tissue approximation [4]. The CS/3T suture had the highest elongation at break (3.37%), indicating its improved flexibility compared to the CS (2.55%) and CS/5T (2.77%) samples. This suggests that the CS/3T suture not only meets mechanical strength requirements, but also retains an appropriate level of elasticity, making it a suitable candidate for clinical applications requiring sutures with improved adaptability to dynamic wound environments. Furthermore, these findings emphasize that chitosan-based sutures reinforced with an optimized concentration of TiO2 can achieve the necessary mechanical performance for surgical applications while preserving their biocompatibility and biodegradability.
Since the tensile strength of the chitosan suture was increased by approximately 12 wt% with 3 wt% addition of TiO2, curcumin was added to the CS/3T sample in the continuation of the study, and the following analyses were carried out on the CS, CS/3T, and CS/3T/C samples.

3.2. Morphological Properties of the Produced Sutures

The surface morphology of the produced sutures was analyzed using SEM. Figure 1 shows that both the blank and doped sutures exhibited a smooth and homogeneous surface morphology without bubbles or pores. The cross-sections of the sutures were round-shaped, indicating uniformity in fiber formation. The measured diameters of the sutures were 76.69 µm for CS, 78.15 µm for CS/3T, and 77.10 µm for CS/3T/Cur, all of which fall within the 7-0 suture range (70–99 µm) as defined by the USP. The SEM images confirm that TiO2 nanoparticles and curcumin were successfully incorporated into the chitosan suture structure, maintaining a uniform distribution.
In the studies in the literature, working at a high chitosan concentration such as 4 wt% and using ethanol in the coagulation bath leads to rapid and uncontrolled coagulation, often resulting in surface irregularities [26,51,56]. Additionally, coagulation in alkaline bath conditions further accelerates the phase separation process by deprotonating the charged amino groups of chitosan, allowing acetic acid and ethanol to demix more easily [26,57,58]. This rapid coagulation disrupts polymer chain organization, leading to uneven fiber morphology [26,51,56]. However, as demonstrated in Figure 1, SEM images confirm that the fiber surfaces obtained in this study are smooth and free of irregularities, despite using a high chitosan concentration (4%) and NaOH in the coagulation bath. This is likely due to the dry jet–wet spinning process, which introduces a critical air-gap stage before coagulation. Unlike wet spinning, where the polymer solution is extruded directly into the bath, the 105 mm air gap in this study allows polymer chains to partially align and stabilize under the influence of gravity before coagulation occurs. This controlled pre-orientation minimizes abrupt phase separation and prevents the coagulant from deeply penetrating the polymer matrix, leading to a more uniform and smoother fiber surface.

3.3. Physicochemical and Mechanical Properties of the Produced Sutures

The FTIR spectra of neat, TiO2, and curcumin-added sutures are given in Figure 2. The strong and broad band in the region 3471–3244 cm−1 corresponds to symmetric vibration of N-H and O-H. The absorption bands at 2931 and 2860 cm−1 can be attributed to methylene and methyl groups C-H stretching vibrations. The bands at 1650 cm−1 were characteristic of the C=O stretching of amide I, proving the presence of remaining N-acetyl groups in the structure of chitosan. The bands at 1585 cm−1 and 1156 cm−1 were corresponding to N-H bending of amide II and asymmetric stretching of the C-O-C bridge in the glucosamine ring, respectively. These bands overlap with the spectra of chitosan samples reported in previous studies in the literature [59,60]. It is seen that the intensities of the N-H, O-H band vibrations in the 3471–3244 cm−1 region and amide II band vibrations at 1585 cm−1 decrease with the addition of TiO2 and curcumin to the chitosan suture structure. These decreases were caused by the interaction between the additives and chitosan [61]. The characteristic Ti–O stretching vibration of TiO2 typically appears around 600 cm−1 in FTIR spectra [62]. However, in the CS/3T suture, this band is observed at 520 cm−1, indicating a slight shift. This shift suggests an interaction between TiO2 and the chitosan matrix, likely due to covalent or hydrogen bonding. The presence of this band confirms the successful incorporation of TiO2 within the suture structure. Additionally, a new vibrational band at 1502 cm−1 was observed exclusively in the CS/3T/C sample, which was not present in the other sutures. This band corresponds to the C=O stretching vibration of the benzene ring in the curcumin structure, confirming the successful incorporation of curcumin within the suture matrix [63].
The mechanical properties of the produced sutures are given in Table 2. The tensile strength of the CS suture was 168.63 MPa, while it was 150.90 MPa in the literature for wet-spun fibers produced at the same chitosan concentration [51]. This difference in mechanical performance is due to the production carried out with the dry jet–wet spinning process in this study. Similar results were seen in the study of Notin et al., where it was stated that physical treatment during the dry jet process improved the mechanical performance without crosslinking or post-treatment [64]. As mentioned in Section 3.1, the mechanical performance of the suture increased with the covalent bonds established between chitosan and TiO2 with the TiO2 addition. However, as shown in Table 2, the addition of curcumin led to a significant decrease in mechanical performance, with the tensile strength dropping to 128.10 MPa in the CS/3T/C sample. While the specific additive differs, a similar trend was observed in the study of Silva et al. It was observed that the tensile strength of N-Acetyl-D-Glucosamine-loaded chitosan fibers decreased by approximately 30% [4]. This decrease in mechanical performance was attributed to the decrease in secondary bond interactions caused by additive–polymer interactions [4]. This comparison is not intended to equate the two materials directly but rather to illustrate that the introduction of certain bioactive additives into a polymer matrix can disrupt intermolecular interactions, leading to reduced mechanical performance. Likewise, in this study, the weakening effect can be attributed to curcumin-induced disruptions in the polymer network, leading to reduced polymer chain interactions. Additionally, the increased swelling behavior further contributed to the mechanical deterioration. As previously mentioned, according to the USP standards, the minimum breaking force required for 7-0 surgical sutures is 0.785 N. The CS/3T/C suture exhibited the lowest breaking strength at 0.57 N, significantly below this threshold. This reduction in breaking strength correlates with the decrease in tensile strength and suggests that the mechanical stability of the CS/3T/C suture was compromised due to curcumin incorporation.
Elongation at break is another critical factor that influences the functionality of surgical sutures. Sutures must exhibit sufficient flexibility to accommodate tissue movements, particularly during swelling and contraction in the wound area. The CS/3T/C suture exhibited an elongation at break of 2.5%, indicating a slight reduction in flexibility compared to the CS suture. This decrease in elongation suggests that curcumin incorporation may have altered the polymer network, potentially reducing its ability to accommodate tissue dynamics.
On the other hand, the degree of swelling significantly affects the mechanical integrity of the suture. The swelling rates of the produced sutures after 24 h of PBS incubation were determined as 124% for CS, 99% for CS/3T, and 180% for CS/3T/C. As shown in Table 2, the addition of curcumin resulted in a decrease in tensile strength, which correlates with the significant increase in swelling behavior. In the study of Albanna et al., it was stated that increased swelling in chitosan-based sutures leads to a reduction in mechanical performance due to water absorption, which disrupts polymer chain interactions and weakens structural integrity [65]. Similarly, studies have demonstrated that curcumin incorporation into polymeric matrices can enhance swelling behavior due to its interaction with the polymer network. For instance, in the study of Ciftci et al., PVA/chitosan composite mats loaded with curcumin showed that curcumin increased the swelling capacity by affecting the polymer network structure and hydrophilicity, which in turn influenced mechanical stability [66]. Furthermore, in the study of Handy and Saeed, it was found that curcumin incorporation into chitosan-based nanocomposites altered the hydration properties of the polymer, resulting in increased swelling ratios and decreased mechanical strength. This effect was attributed to curcumin-induced structural modifications within the chitosan matrix, leading to reduced polymer chain interactions and higher water uptake [67]. Similarly, in this study, the highest swelling ratio (180%) was observed in curcumin-loaded sutures (CS/3T/C), which also exhibited the lowest tensile strength and breaking strength. This suggests that the excessive swelling behavior induced by curcumin further contributed to the mechanical deterioration of the sutures.

3.4. Radical Scavenging Activities of the Produced Sutures

Free radicals cause many diseases and aging by damaging cells [68]. The use of antioxidant agents helps prevent the progression of diseases by capturing free radicals in human and animal cells [69,70]. To determine the antioxidant activity of the produced sutures, DPPH was used as a stable free radical that acts as a hydrogen and electron acceptor. As seen in Figure 3, the scavenging ability of CS suture was determined to be approximately 22.36%, and this value was very close to the scavenging ability determined in the study of Shanmugam et. al., who studied the same chitosan concentration (5 mg/mL) [71]. The scavenging mechanism of chitosan was attributed to an unshared electron pair of electrons of nitrogen in the C-2 position of the chitosan. In an acidic medium, this unshared electron catches the released proton and forms NH3+. Hydrogen ions of NH3+ can stabilize the free radicals causing various diseases by reacting with them [72,73]. The DPPH scavenging activity of the CS/3T was decreased to approximately 9.95%. This decrease in the DPPH scavenging activity of CS/3T is thought to be due to the binding of some –NH2 groups at the C-2 position with TiO2, which are responsible for the scavenging activity in chitosan. In addition to the blocking of the active groups of chitosan, the weak antioxidant activity of TiO2, as stated in the literature, was also effective in this decrease [74,75]. The CS/3T/CUR suture shows time-dependent activity, which confirms that the radical scavenging activity of the sutures was linked to the release of the active ingredient from the structure, similar to the literature [76,77]. As seen in the figure, while the DPPH scavenging activity of the CS/3T/CUR suture was initially between those of the CS and CS/3T sutures, it caught up with the CS suture at the 66th hour with the release of curcumin in the structure. It then continued to increase until the 125th hour and stabilized at approximately 43%.

3.5. In Vitro Characterization of the Produced Sutures

Biocidal performance of the produced sutures against S. aureus was evaluated. The CS, CS/3T, and CS/3T/C suture swatches were challenged with 105 CFU concentration S. aureus and the results are given in Figure 4A. Although chitosan is known as antibacterial in the literature, the amine group must be positively charged in order for chitosan to show antibacterial activity. Amine groups can only affect negatively charged groups on the bacterial cell surface when they are positively charged [78,79]. In other words, the antibacterial properties of chitosan are directly affected by the pH of the environment, and for this reason, the antibacterial activity of the suture produced only from chitosan in this study reached only 43% after 12 h. As shown in Figure 4A, the TiO2-doped sample showed similar antibacterial activity to CS. It is well known that TiO2 nanoparticles exhibit antibacterial properties mainly through a photocatalytic mechanism, where they generate reactive oxygen species (ROS), including hydroxyl radicals (–OH) and superoxide anions (O2−), under UV or visible light irradiation [38,62,80,81]. These ROS species are highly reactive and can damage bacterial membranes, proteins, and DNA, ultimately leading to cell death. However, in the absence of light, the generation of ROS is significantly reduced, limiting the antibacterial activity of TiO2. As the bacterial tests in this study were performed in a dark environment, TiO2 could not be activated to produce ROS, which explains why no significant increase in antibacterial activity was observed compared to the control (CS) sample. On the other hand, curcumin provides antibacterial activity by settling on the cell membrane of bacteria and preventing the cell from dividing and multiplying [82], and as shown in Figure 4A, the curcumin-added suture showed 83.39% effectiveness in just 3 h and provided 98.87% bacterial inactivation at the end of 24 h.
The in vitro release profile of curcumin from CS/3T/C suture was analyzed at 37 °C in PBS (at pH 7.4) solution as a simulation of body fluid, and the cumulative release against incubation time is shown in Figure 4B. The curcumin-loaded suture showed a burst release of approximately 40% in the first two hours. Although different materials were used, a similar burst release phenomenon has been reported in the literature. For example, in the study by Rezaei and Nasirpour, curcumin-loaded almond gum/PVA nanofibers exhibited a release of approximately 27% within 2 h [83]. Rezaei and Nasirpour attributed this burst release to the weaker binding of curcumin on the fiber surface to the polymer and its higher diffusion tendency. Similarly, in this study, it is hypothesized that curcumin near the surface of the high surface area suture was released more rapidly into the simulated body fluid. Although the polymer matrices are different, the general mechanism of burst release by surface-bound curcumin may be comparable. The literature suggests that burst release assists wound healing by providing immediate relief followed by a sustained release phase [84,85]. The environment in which the bioactive substance is located, along with its interaction with the surroundings, plays a crucial role in its release performance. For instance, Bui et al. demonstrated that the addition of Tween 80 to PBS significantly affects the release of curcumin from Zein nanofibers. Their study showed that both the burst release and the total release amount increased as the Tween 80 concentration increased. Specifically, while the curcumin release was only 2.5% in PBS without Tween 80 after 72 h, it reached 11.5% in PBS containing 10% Tween 80 [86]. As depicted in Figure 4B, following the initial burst release within the first two hours, the sustained release of curcumin continued for up to 25 h, ultimately reaching a total release of approximately 77%. The curcumin release profile was consistent with the antibacterial test results. After three hours, curcumin release reached approximately 40%, corresponding to an 83% bacterial inactivation rate in the CS/3T/C suture. By the 12th hour, with a curcumin release of 62%, bacterial inactivation had reached nearly 99%. It is thought that burst release will have a positive effect on the healing of the injured area by cleaning the suture area from bacteria [87].
The hydroxyapatite layer formed on the surface of a material in contact with body fluids as a result of various biological reactions provides information about the bioactivity of the material [88,89]. In in vitro applications, 10 × SBF solution is used to accelerate the formation of this layer [90]. Figure 1 (After SBF) demonstrates bonelike crystalline hydroxyapatite layer formation on produced suture samples after 3 and 14 days of incubation. Granular core apatite formation in this layer showed a cauliflower-like morphology that is characteristic for bioactive surfaces, similar to our previous study [89]. The smooth surfaces of the sutures seen in Figure 1 (Before SBF) were covered with hydroxyapatite and completely change the morphology of the sutures. In addition, an increase in suture diameters was observed due to the accumulation of hydroxyapatite on their surfaces. Similar results were seen in the study by Boccaccini et al., who coated bioactive glass on polyglactin 910 sutures. It was observed that an approximately 15 µm HA layer was formed on the surface of the sutures after 21 days of incubation in SBF solution [91]. In addition to SEM analysis, EDS was used to determine the chemical composition of the cauliflower-like clusters on the CS/3T/C suture (Figure 4C,D). The Ca/P ratio on the surface of the CS/3T/C suture increased from 1.33 after 3 days of incubation to 3.24 after 14 days in SBF. The Ca and P elements, which were found to be concentrated in the nucleation regions, confirm that the formed layer on the scaffold consists of apatite.
Figure 4E showed the FTIR spectra of the chemical composition of the apatite deposit formed on the CS/3T/C suture after 3 and 14 days of incubation in SBF. The band at 798 cm−1 corresponded to the P-O bond stretching, indicating the presence of the crystalline phase of the apatite structure deposited on the surface of the CS/3T/C suture [92]. While the band at 1032 cm−1 was associated with the triply degenerated asymmetric stretching of PO₄3−, the band around 873 cm−1 confirmed the presence of phosphate groups within the carbonated apatite structure [93,94]. On the other hand, the vibrations observed around 3379 cm−1 and 1650 cm−1, which significantly increased from day 3 to day 14, corresponded to the O–H stretching of H2O in the apatite layer [92,93,94].
Despite the reduced mechanical properties, the CS/3T/C suture demonstrated superior biological performance as seen in in vitro analysis. The incorporation of curcumin significantly improved antibacterial activity, bioactivity, and antioxidant performance, which are critical factors in reducing infection risks and accelerating wound healing. In surgical applications where infection control and bioactivity are prioritized over mechanical strength, such as in soft tissue repair or absorbable sutures, the benefits of curcumin-enhanced sutures may outweigh the mechanical limitations. Moreover, future studies could focus on optimizing the polymeric formulation or incorporating crosslinking strategies to enhance mechanical properties while preserving the biological advantages provided by curcumin.

4. Conclusions

In the present study, the dry jet–wet spinning method was successfully employed in developing smooth and homogeneous surface chitosan sutures with 7-0 suture number. The effects of the TiO2 and curcumin content on the physicochemical, mechanical, morphological, antioxidant, and in vitro biocidal, drug release, and bioactivity properties of the sutures were systematically investigated. In the first part of the study, it was observed that the covalent bonds established between TiO2 and chitosan provided an increase in the mechanical performance of chitosan sutures by up to 12.32% with 3% TiO2 addition. While the addition of curcumin to increase the healing performance of the suture in the surgery area provided significant improvements in this sense, it caused a decrease in mechanical performance. In conclusion, curcumin-added chitosan sutures will contribute to the healing of the surgery area due to the improved antioxidant and biocidal activity and controlled release of the drug. To my knowledge, no previous studies have investigated curcumin-loaded TiO2-reinforced chitosan surgical sutures. This pioneering work will pave the way for further research in this promising area and fills an important gap in the literature. By integrating innovative materials, this study not only expands the potential applications of advanced surgical sutures, but future studies can build on this foundation to improve their mechanical performance and explore broader biomedical applications.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Acknowledgments

I would like to thank Şeyma Duman and her team for generously providing the TiO2 powder used in this study. I would also like to express my gratitude to Mehmet Orhan for his valuable support in conducting the bacterial tests.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Joseph, B.; James, J.; Kalarikkal, N.; Thomas, S. Advances in biopolymer based surgical sutures. In Book Advanced Technologies and Polymer Materials for Surgical Sutures, 1st ed.; Thomas, S., Coates, P., Whiteside, B., Joseph, B., Nair, K., Eds.; Woodhead Publishing: Cambridge, UK, 2023; pp. 1–10. [Google Scholar]
  2. Öksüz, K.E.; Kurt, B.; İnan, Z.D.Ş.; Hepokur, C. Novel bioactive glass/graphene oxide-coated surgical sutures for soft tissue regeneration. ACS Omega 2023, 8, 21628–21641. [Google Scholar] [CrossRef]
  3. Tan, Y.; Rajoka, M.S.R.; Ke, Z.; Mehwish, H.M.; Deng, W.; Li, J.; Qin, W.; Zhao, L.; Wu, Y. Effect of squid cartilage chitosan molecular structure on the properties of its monofilament as an absorbable surgical suture. Polymers 2022, 14, 1306. [Google Scholar] [CrossRef]
  4. da Silva, M.C.; da Silva, H.N.; Alves Leal Cruz, R.D.C.; Sagoe Amoah, S.K.; de Lima Silva, S.M.; Lia Fook, M.V. N-acetyl-D-glucosamine-loaded chitosan filaments biodegradable and biocompatible for use as absorbable surgical suture materials. Materials 2019, 12, 1807. [Google Scholar] [CrossRef]
  5. Li, H.; Cheng, F.; Chávez-Madero, C.; Choi, J.; Wei, X.; Yi, X.; Zheng, T.; He, J. Manufacturing and physical characterization of absorbable oxidized regenerated cellulose braided surgical sutures. Int. J. Biol. Macromol. 2019, 134, 56–62. [Google Scholar] [CrossRef] [PubMed]
  6. Dennis, C.; Sethu, S.; Nayak, S.; Mohan, L.; Morsi, Y.; Manivasagam, G. Suture materials—Current and emerging trends. J. Biomed. Mater. Res. Part A 2016, 104, 1544–1599. [Google Scholar] [CrossRef] [PubMed]
  7. Pillai, C.K.S.; Sharma, C.P. Absorbable polymeric surgical sutures: Chemistry, production, properties, biodegradability, and performance. J. Biomater. Appl. 2010, 25, 291–366. [Google Scholar] [CrossRef] [PubMed]
  8. Barbosa, M.C.D.S.; Silva, H.N.D.; Lopes, D.D.S.; Wanderley, W.F.; Rosendo, R.A.; Penha, E.S.D.; de Medeiros, L.A.D.M.; Silva, S.M.d.L.; Fook, M.V.L. Biodegradable Chitosan Sutures Enhanced with N-Acetyl-D-Glucosamine: Comparative Study with Catgut Sutures. Mater. Res. 2024, 27, e20240278. [Google Scholar] [CrossRef]
  9. Younesi, M.; Donmez, B.O.; Islam, A.; Akkus, O. Heparinized collagen sutures for sustained delivery of PDGF-BB: Delivery profile and effects on tendon-derived cells In-Vitro. Acta Biomater. 2016, 41, 100–109. [Google Scholar] [CrossRef]
  10. Shao, K.; Han, B.; Gao, J.; Jiang, Z.; Liu, W.; Liu, W.; Liang, Y. Fabrication and feasibility study of an absorbable diacetyl chitin surgical suture for wound healing. J. Biomed. Mater. Res. Part B Appl. Biomater. 2016, 104, 116–125. [Google Scholar] [CrossRef] [PubMed]
  11. Chu, C.C.; Williams, D.F. The effect of gamma irradiation on the enzymatic degradation of polyglycolic acid absorbable sutures. J. Biomed. Mater. Res. 1983, 17, 1029–1040. [Google Scholar] [CrossRef]
  12. Im, J.N.; Kim, J.K.; Kim, H.K.; In, C.H.; Lee, K.Y.; Park, W.H. In vitro and in vivo degradation behaviors of synthetic absorbable bicomponent monofilament suture prepared with poly (p-dioxanone) and its copolymer. Polym. Degrad. Stab. 2007, 92, 667–674. [Google Scholar] [CrossRef]
  13. Lim, T.Y.; Poh, C.K.; Wang, W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J. Mater. Sci. Mater. Med. 2009, 20, 1669–1675. [Google Scholar] [CrossRef] [PubMed]
  14. Katz, A.R.; Mukherjee, D.P.; Kaganov, A.L.; Gordon, S. A new synthetic monofilament absorbable suture made from polytrimethylene carbonate. Surg. Gynecol. Obstet. 1985, 161, 213–222. [Google Scholar]
  15. Hu, J.; Song, Y.; Zhang, C.; Huang, W.; Chen, A.; He, H.; Zhang, S.; Chen, Y.; Tu, C.; Liu, J.; et al. Highly aligned electrospun collagen/polycaprolactone surgical sutures with sustained release of growth factors for wound regeneration. ACS Appl. Bio Mater. 2020, 3, 965–976. [Google Scholar] [CrossRef]
  16. Viju, S.; Thilagavathi, G. Effect of chitosan coating on the characteristics of silk-braided sutures. J. Ind. Text. 2013, 42, 256–268. [Google Scholar] [CrossRef]
  17. Dash, M.; Chiellini, F.; Ottenbrite, R.M.; Chiellini, E. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog. Polym. Sci. 2011, 36, 981–1014. [Google Scholar] [CrossRef]
  18. Rodrigues, S.; Dionísio, M.; Remunan Lopez, C.; Grenha, A. Biocompatibility of chitosan carriers with application in drug delivery. J. Funct. Biomater. 2012, 3, 615–641. [Google Scholar] [CrossRef]
  19. Martău, G.A.; Mihai, M.; Vodnar, D.C. The use of chitosan, alginate, and pectin in the biomedical and food sector—Biocompatibility, bioadhesiveness, and biodegradability. Polymers 2019, 11, 1837. [Google Scholar] [CrossRef] [PubMed]
  20. Rizeq, B.R.; Younes, N.N.; Rasool, K.; Nasrallah, G.K. Synthesis, bioapplications, and toxicity evaluation of chitosan-based nanoparticles. Int. J. Mol. Sci. 2019, 20, 5776. [Google Scholar] [CrossRef] [PubMed]
  21. Tan, H.; Ma, R.; Lin, C.; Liu, Z.; Tang, T. Quaternized chitosan as an antimicrobial agent: Antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci. 2013, 14, 1854–1869. [Google Scholar] [CrossRef]
  22. Panda, P.K.; Sadeghi, K.; Park, K.; Seo, J. Regeneration approach to enhance the antimicrobial and antioxidant activities of chitosan for biomedical applications. Polymers 2022, 15, 132. [Google Scholar] [CrossRef] [PubMed]
  23. Khalil, K.D.; Bashal, A.H.; Habeeb, T.; Abu-Dief, A.M. Synergistic antibacterial and anticancer activity in gadolinium–chitosan nanocomposite films: A novel approach for biomedical applications. Appl. Organomet. Chem. 2024, 38, e7531. [Google Scholar] [CrossRef]
  24. Matica, M.A.; Aachmann, F.L.; Tøndervik, A.; Sletta, H.; Ostafe, V. Chitosan as a wound dressing starting material: Antimicrobial properties and mode of action. Int. J. Mol. Sci. 2019, 20, 5889. [Google Scholar] [CrossRef]
  25. Montenegro, R.; Godeiro, J.R.G. Chitosan based suture–focusing on the real advantages of an outstanding biomaterial. Adv. Chitin Sci. 2014, 14, 211–216. [Google Scholar]
  26. Perrin, N.; Mohammadkhani, G.; Moghadam, F.H.; Delattre, C.; Zamani, A. Biocompatible fibers from fungal and shrimp chitosans for suture application. Curr. Res. Biotechnol. 2022, 4, 530–536. [Google Scholar] [CrossRef]
  27. Farrokhi, H.; Koosha, M.; Nasirizadeh, N.; Salari, M.; Abdouss, M.; Li, T.; Gong, Y. The Effect of Nanoclay Type on the Mechanical Properties and Antibacterial Activity of Chitosan/PVA Nanocomposite Films. J. Compos. Sci. 2024, 8, 255. [Google Scholar] [CrossRef]
  28. Aryaei, A.; Jayatissa, A.H.; Jayasuriya, A.C. Mechanical and biological properties of chitosan/carbon nanotube nanocomposite films. J. Biomed. Mater. Res. Part A 2014, 102, 2704–2712. [Google Scholar] [CrossRef] [PubMed]
  29. Marroquin, J.B.; Rhee, K.Y.; Park, S.J. Chitosan nanocomposite films: Enhanced electrical conductivity, thermal stability, and mechanical properties. Carbohydr. Polym. 2013, 92, 1783–1791. [Google Scholar] [CrossRef] [PubMed]
  30. Mahalakshmi, S.; Vijaya, P. Evaluation of in-vitro biocompatibility and antimicrobial activities of titanium dioxide (TiO2) nanoparticles by hydrothermal method. Nano Biomed. Eng. 2021, 13, 36–43. [Google Scholar] [CrossRef]
  31. Kiran, A.S.K.; Kumar, T.S.; Sanghavi, R.; Doble, M.; Ramakrishna, S. Antibacterial and bioactive surface modifications of titanium implants by PCL/TiO2 nanocomposite coatings. Nanomaterials 2018, 8, 860. [Google Scholar] [CrossRef]
  32. Khan, S.; Garg, M.; Chockalingam, S.; Gopinath, P.; Kundu, P.P. TiO2 doped chitosan/poly (vinyl alcohol) nanocomposite film with enhanced mechanical properties for application in bone tissue regeneration. Int. J. Biol. Macromol. 2020, 143, 285–296. [Google Scholar] [CrossRef] [PubMed]
  33. Cano, L.; Pollet, E.; Avérous, L.; Tercjak, A. Effect of TiO2 nanoparticles on the properties of thermoplastic chitosan-based nano-biocomposites obtained by mechanical kneading. Compos. Part A Appl. Sci. Manuf. 2017, 93, 33–40. [Google Scholar] [CrossRef]
  34. Ravandi, R.; Heris, S.Z.; Hemmati, S.; Aghazadeh, M.; Davaran, S.; Abdyazdani, N. Effects of chitosan and TiO2 nanoparticles on the antibacterial property and ability to self-healing of cracks and retrieve mechanical characteristics of dental composites. Heliyon 2024, 10, e27734. [Google Scholar] [CrossRef] [PubMed]
  35. Prajapati, S.K.; Malaiya, A.; Kesharwani, P.; Soni, D.; Jain, A. Biomedical applications and toxicities of carbon nanotubes. Drug Chem. Toxicol. 2022, 45, 435–450. [Google Scholar] [CrossRef] [PubMed]
  36. Merino, D.; Tomadoni, B.; Salcedo, M.F.; Mansilla, A.Y.; Casalongué, C.A.; Alvarez, V.A. Nanoclay as carriers of bioactive molecules applied to agriculture. In Handbook of Nanomaterials and Nanocomposites for Energy and Environmental Applications, 1st ed.; Kharissova, O.V., Torres-Martínez, L.M., Kharisov, B.I., Eds.; Springer: Cham, Switzerland, 2022; pp. 1–22. [Google Scholar]
  37. Jeon, J.D.; Kim, M.J.; Kwak, S.Y. Effects of addition of TiO2 nanoparticles on mechanical properties and ionic conductivity of solvent-free polymer electrolytes based on porous P (VdF-HFP)/P (EO-EC) membranes. J. Power Sources 2006, 162, 1304–1311. [Google Scholar] [CrossRef]
  38. Qu, L.; Chen, G.; Dong, S.; Huo, Y.; Yin, Z.; Li, S.; Chen, Y. Improved mechanical and antimicrobial properties of zein/chitosan films by adding highly dispersed nano-TiO2. Ind. Crops Prod. 2019, 130, 450–458. [Google Scholar] [CrossRef]
  39. El-Wakil, N.A.; Hassan, E.A.; Abou-Zeid, R.E.; Dufresne, A. Development of wheat gluten/nanocellulose/titanium dioxide nanocomposites for active food packaging. Carbohydr. Polym. 2015, 124, 337–346. [Google Scholar] [CrossRef] [PubMed]
  40. Nocito, M.C.; De Luca, A.; Prestia, F.; Avena, P.; La Padula, D.; Zavaglia, L.; Sirianni, R.; Casaburi, I.; Puoci, F.; Chimento, A.; et al. Antitumoral activities of curcumin and recent advances to improve its oral bioavailability. Biomedicines 2021, 9, 1476. [Google Scholar] [CrossRef] [PubMed]
  41. Zheng, D.; Huang, C.; Huang, H.; Zhao, Y.; Khan, M.R.U.; Zhao, H.; Huang, L. Antibacterial mechanism of curcumin: A review. Chem. Biodivers. 2020, 17, e2000171. [Google Scholar] [CrossRef]
  42. Chen, J.; He, Z.M.; Wang, F.L.; Zhang, Z.S.; Liu, X.Z.; Zhai, D.D.; Chen, W.D. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. Eur. J. Pharmacol. 2016, 772, 33–42. [Google Scholar] [CrossRef]
  43. Jennings, M.R.; Parks, R.J. Curcumin as an antiviral agent. Viruses 2020, 12, 1242. [Google Scholar] [CrossRef] [PubMed]
  44. Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, 1st ed; Aggarwal, B.B., Surh, Y., Shishodia, S., Eds.; Springer Science & Business Media: New York, NY, USA, 2007; pp. 105–125. [Google Scholar]
  45. Kim, D.C.; Ku, S.K.; Bae, J.S. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012, 45, 221–226. [Google Scholar] [CrossRef]
  46. Riyad, P.; Purohit, A.; Karishma, S.; Ram, H. Atherosclerotic plaque regression and HMG-CoA reductase inhibition potential of curcumin: An integrative omics and in-vivo study. J. Appl. Biol. Biotechnol 2022, 10, 129–135. [Google Scholar]
  47. Park, J.; Conteas, C.N. Anti-carcinogenic properties of curcumin on colorectal cancer. World J. Gastrointest. Oncol. 2010, 2, 169. [Google Scholar] [CrossRef]
  48. Puneeth, H.R.; Sharada, A.C. Antioxidant and hypoglycemic effects of curcumin pyrazole derivatives. Int. J. Pharm. Pharm. Sci. 2015, 7, 244–249. [Google Scholar]
  49. Bulut, B.; Duman, Ş. Effects of calcination temperature on hydrothermally synthesized titanium dioxide submicron powders. Konya J. Eng. Sci. 2021, 9, 676–685. [Google Scholar] [CrossRef]
  50. Yudin, V.E.; Dobrovolskaya, I.P.; Neelov, I.M.; Dresvyanina, E.N.; Popryadukhin, P.V.; Ivan’kova, E.M.; Elokhovskii, V.Y.; Kasatkin, I.A.; Okrugin, B.M.; Morganti, P. Wet spinning of fibers made of chitosan and chitin nanofibrils. Carbohydr. Polym. 2014, 108, 176–182. [Google Scholar] [CrossRef] [PubMed]
  51. Mohammadkhani, G.; Kumar Ramamoorthy, S.; Adolfsson, K.H.; Mahboubi, A.; Hakkarainen, M.; Zamani, A. New solvent and coagulating agent for development of chitosan fibers by wet spinning. Polymers 2021, 13, 2121. [Google Scholar] [CrossRef] [PubMed]
  52. Dresvyanina, E.N.; Dobrovol’Skaya, I.P.; Popryadukhin, P.V.; Yudin, V.E.; Ivan’Kova, E.M.; Elokhovskii, V.Y.; Khomenko, A.Y. Influence of spinning conditions on properties of chitosan fibers. Fibre Chem. 2013, 44, 280–283. [Google Scholar] [CrossRef]
  53. ASTM D2256/D2256M-21; Standard Test Method for Tensile Properties of Yarns by the Single-Strand Method. ASTM: West Conshohocken, PA, USA, 2022.
  54. Mavis, B.; Demirtaş, T.T.; Gümüşderelioğlu, M.; Gündüz, G.; Çolak, Ü. Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate. Acta Biomater. 2009, 5, 3098–3111. [Google Scholar] [CrossRef]
  55. Hussein, E.M.; Desoky, W.M.; Hanafy, M.F.; Guirguis, O.W. Effect of TiO2 nanoparticles on the structural configurations and thermal, mechanical, and optical properties of chitosan/TiO2 nanoparticle composites. J. Phys. Chem. Solids 2021, 152, 109983. [Google Scholar] [CrossRef]
  56. Knaul, J.; Hooper, M.; Chanyi, C.; Creber, K.A. Improvements in the drying process for wet-spun chitosan fibers. J. Appl. Polym. Sci. 1998, 69, 1435–1444. [Google Scholar] [CrossRef]
  57. Nechyporchuk, O.; Yang Nilsson, T.; Ulmefors, H.; Köhnke, T. Wet spinning of chitosan fibers: Effect of sodium dodecyl sulfate adsorption and enhanced dope temperature. ACS Appl. Polym. Mater. 2020, 2, 3867–3875. [Google Scholar] [CrossRef]
  58. Pantić, M.; Maver, U.; Rožanc, J.; Vihar, B.; Andrejč, D.C.; Knez, Ž.; Novak, Z. Evaluation of ethanol-induced chitosan aerogels with human osteoblast cells. Int. J. Biol. Macromol. 2023, 253, 126694. [Google Scholar] [CrossRef] [PubMed]
  59. Queiroz, M.F.; Teodosio Melo, K.R.; Sabry, D.A.; Sassaki, G.L.; Rocha, H.A.O. Does the use of chitosan contribute to oxalate kidney stone formation? Mar. Drugs 2014, 13, 141–158. [Google Scholar] [CrossRef] [PubMed]
  60. Ibekwe, C.A.; Oyatogun, G.M.; Esan, T.A.; Oluwasegun, K.M. Synthesis and characterization of chitosan/gum arabic nanoparticles for bone regeneration. Am. J. Mater. Sci. Eng. 2017, 5, 28–36. [Google Scholar]
  61. Rachtanapun, P.; Klunklin, W.; Jantrawut, P.; Jantanasakulwong, K.; Phimolsiripol, Y.; Seesuriyachan, P.; Leksawasdi, N.; Chaiyaso, T.; Ruksiriwanich, W.; Phongthai, S.; et al. Characterization of chitosan film incorporated with curcumin extract. Polymers 2021, 13, 963. [Google Scholar] [CrossRef] [PubMed]
  62. Karthikeyan, K.T.; Nithya, A.; Jothivenkatachalam, K. Photocatalytic and antimicrobial activities of chitosan-TiO2 nanocomposite. Int. J. Biol. Macromol. 2017, 104, 1762–1773. [Google Scholar] [CrossRef] [PubMed]
  63. Musielak, E.; Feliczak-Guzik, A.; Jaroniec, M.; Nowak, I. Photodynamic light-triggered release of curcumin from hierarchical FAU zeolite. Catalysts 2023, 13, 394. [Google Scholar] [CrossRef]
  64. Notin, L.; Viton, C.; David, L.; Alcouffe, P.; Rochas, C.; Domard, A. Morphology and mechanical properties of chitosan fibers obtained by gel-spinning: Influence of the dry-jet-stretching step and ageing. Acta Biomater. 2006, 2, 387–402. [Google Scholar] [CrossRef]
  65. Albanna, M.Z.; Bou-Akl, T.H.; Walters, H.L., III; Matthew, H.W. Improving the mechanical properties of chitosan-based heart valve scaffolds using chitosan fibers. J. Mech. Behav. Biomed. Mater. 2012, 5, 171–180. [Google Scholar] [CrossRef] [PubMed]
  66. Ciftci, F.; Özarslan, A.C.; Evcimen Duygulu, N. Production and comprehensive characterization of PVA/chitosan transdermal composite mats loaded with bioactive curcumin; evaluation of its release kinetics, antioxidant, antimicrobial, and biocompatibility features. J. Appl. Polym. Sci. 2024, 141, e55874. [Google Scholar] [CrossRef]
  67. Abd El-Hady, M.M.; Saeed, S.E.S. Antibacterial properties and pH sensitive swelling of insitu formed silver-curcumin nanocomposite based chitosan hydrogel. Polymers 2020, 12, 2451. [Google Scholar] [CrossRef]
  68. Pham-Huy, L.A.; He, H.; Pham-Huy, C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. IJBS 2008, 4, 89. [Google Scholar] [CrossRef]
  69. Yuan, Y.; Tan, W.; Zhang, J.; Li, Q.; Guo, Z. Water-soluble amino functionalized chitosan: Preparation, characterization, antioxidant and antibacterial activities. Int. J. Biol. Macromol. 2022, 217, 969–978. [Google Scholar] [CrossRef]
  70. Rasheed, U.; Kiani, M.N.; Butt, M.S.; Saeed, H.; Hanif, R.; Anwar, S. Fabrication and biocompatibility of neem/chitosan coated silk sutures for infection control and wound healing. J. King Saud Univ. -Sci. 2024, 36, 103435. [Google Scholar] [CrossRef]
  71. Shanmugam, A.; Subhapradha, N.; Suman, S.; Ramasamy, P.; Saravanan, R.; Shanmugam, V.; Srinivasan, A. Characterization of biopolymer “chitosan” from the shell of donacid clam Donax scortum (Linnaeus, 1758) and its antioxidant activity. Int. J. Pharm. Pharm. Sci 2012, 4, 460–465. [Google Scholar]
  72. Si Trung, T.; Bao, H.N.D. Physicochemical properties and antioxidant activity of chitin and chitosan prepared from pacific white shrimp waste. Int. J. Carbohydr. Chem. 2015, 2015, 706259. [Google Scholar] [CrossRef]
  73. Xia, W.; Liu, P.; Zhang, J.; Chen, J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocoll. 2011, 25, 170–179. [Google Scholar] [CrossRef]
  74. Zhang, X.; Liu, Y.; Yong, H.; Qin, Y.; Liu, J.; Liu, J. Development of multifunctional food packaging films based on chitosan, TiO2 nanoparticles and anthocyanin-rich black plum peel extract. Food Hydrocoll. 2019, 94, 80–92. [Google Scholar] [CrossRef]
  75. Ullattil, S.G.; Narendranath, S.B.; Pillai, S.C.; Periyat, P. Black TiO2 nanomaterials: A review of recent advances. Chem. Eng. J. 2018, 343, 708–736. [Google Scholar] [CrossRef]
  76. Kazan, A.; Demirci, F. Olive leaf extract incorporated chitosan films for active food packaging. Konya J. Eng. Sci. 2023, 11, 1061–1072. [Google Scholar] [CrossRef]
  77. Bi, F.; Qin, Y.; Chen, D.; Kan, J.; Liu, J. Development of active packaging films based on chitosan and nano-encapsulated luteolin. Int. J. Biol. Macromol. 2021, 182, 545–553. [Google Scholar] [CrossRef] [PubMed]
  78. Zhang, Q.; Qiao, Y.; Li, C.; Lin, J.; Han, H.; Li, X.; Mao, J.; Wang, F.; Wang, L. Chitosan/gelatin-tannic acid decorated porous tape suture with multifunctionality for tendon healing. Carbohydr. Polym. 2021, 268, 118246. [Google Scholar] [CrossRef] [PubMed]
  79. Zhang, Q.; Qiao, Y.; Zhu, J.; Li, Y.; Li, C.; Lin, J.; Li, X.; Han, H.; Mao, J.; Wang, F.; et al. Electroactive and antibacterial surgical sutures based on chitosan-gelatin/tannic acid/polypyrrole composite coating. Compos. Part B Eng. 2021, 223, 109140. [Google Scholar] [CrossRef]
  80. Zhang, X.; Xiao, G.; Wang, Y.; Zhao, Y.; Su, H.; Tan, T. Preparation of chitosan-TiO2 composite film with efficient antimicrobial activities under visible light for food packaging applications. Carbohydr. Polym. 2017, 169, 101–107. [Google Scholar] [CrossRef] [PubMed]
  81. Sagadevan, S.; Lett, J.A.; Vennila, S.; Prasath, P.V.; Kaliaraj, G.S.; Fatimah, I.; Léonard, E.; Mohammad, F.; Al-Lohedan, H.A.; Alshahateet, S.F.; et al. Photocatalytic activity and antibacterial efficacy of titanium dioxide nanoparticles mediated by Myristica fragrans seed extract. Chem. Phys. Lett. 2021, 771, 138527. [Google Scholar] [CrossRef]
  82. Li, H.; Jiang, Y.; Yang, J.; Pang, R.; Chen, Y.; Mo, L.; Jiang, Q.; Qin, Z. Preparation of curcumin-chitosan composite film with high antioxidant and antibacterial capacity: Improving the solubility of curcumin by encapsulation of biopolymers. Food Hydrocoll. 2023, 145, 109150. [Google Scholar] [CrossRef]
  83. Rezaei, A.; Nasirpour, A. Evaluation of release kinetics and mechanisms of curcumin and curcumin-β-cyclodextrin inclusion complex incorporated in electrospun almond gum/PVA nanofibers in simulated saliva and simulated gastrointestinal conditions. BioNanoScience 2019, 9, 438–445. [Google Scholar] [CrossRef]
  84. Cam, M.E.; Yildiz, S.; Alenezi, H.; Cesur, S.; Ozcan, G.S.; Erdemir, G.; Edirisinghe, U.; Akakin, D.; Kuruca, D.S.; Kabasakal, L.; et al. Evaluation of burst release and sustained release of pioglitazone-loaded fibrous mats on diabetic wound healing: An in vitro and in vivo comparison study. J. R. Soc. Interface 2020, 17, 20190712. [Google Scholar] [CrossRef]
  85. Huang, X.; Brazel, C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 2001, 73, 121–136. [Google Scholar] [CrossRef]
  86. Bui, H.T.; Chung, O.H.; Park, J.S. Fabrication of electrospun antibacterial curcumin-loaded zein nanofibers. Polymer 2014, 38, 744–751. [Google Scholar] [CrossRef]
  87. Houshyar, S.; Yin, H.; Pope, L.; Zizhou, R.; Dekiwadia, C.; Hill-Yardin, E.L.; MC Yeung, J.; John, S.; Fox, K.; Tran, N.; et al. Smart suture with iodine contrasting nanoparticles for computed tomography. OpenNano 2023, 9, 100120. [Google Scholar] [CrossRef]
  88. Blaker, J.J.; Nazhat, S.N.; Boccaccini, A.R. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials 2004, 25, 1319–1329. [Google Scholar] [CrossRef] [PubMed]
  89. Mutlu, B.; Demirci, F.; Duman, Ş. Investigating the impact of coagulation bath temperature on the properties of biphasic calcium phosphate/poly (vinylidene fluoride)-based membrane scaffold via immersion precipitation. J. Appl. Polym. Sci. 2024, 142, e56375. [Google Scholar] [CrossRef]
  90. Duman, Ş.; Bulut, B. Effect of akermanite powders on mechanical properties and bioactivity of chitosan-based scaffolds produced by 3D-bioprinting. Ceram. Int. 2021, 47, 13912–13921. [Google Scholar] [CrossRef]
  91. Boccaccini, A.R.; Stamboulis, A.G.; Rashid, A.; Roether, J.A. Composite surgical sutures with bioactive glass coating. J. Biomed. Mater. Res. Part B Appl. Biomater. 2003, 67, 618–626. [Google Scholar] [CrossRef]
  92. Sierra, L.A.Q.; Escobar, D.M. Characterization and bioactivity behavior of sol–gel derived bioactive vitroceramic from non-conventional precursors. Boletín De La Soc. Española De Cerámica Y Vidr. 2019, 58, 85–92. [Google Scholar] [CrossRef]
  93. Wei, D.; Zhou, Y.; Jia, D.; Wang, Y. Biomimetic apatite deposited on microarc oxidized anatase-based ceramic coating. Ceram. Int. 2008, 34, 1139–1144. [Google Scholar] [CrossRef]
  94. Mutlu, B.; Demirci, F.; Duman, Ş. Influence of boron incorporated biphasic calcium phosphate on mechanical, thermal, and biological properties of poly (vinylidene fluoride) membrane scaffold. J. Am. Ceram. Soc. 2024, 107, 7274–7288. [Google Scholar] [CrossRef]
Polymers 17 00484 g001
Figure 1. SEM images of the produced sutures before and after SBF (3 days and 14 days incubation).
Figure 1. SEM images of the produced sutures before and after SBF (3 days and 14 days incubation).
Polymers 17 00484 g001
Polymers 17 00484 g002
Figure 2. FTIR spectra of the produced suture samples.
Figure 2. FTIR spectra of the produced suture samples.
Polymers 17 00484 g002
Polymers 17 00484 g003
Figure 3. Radical scavenging activity of the produced sutures at different time intervals.
Figure 3. Radical scavenging activity of the produced sutures at different time intervals.
Polymers 17 00484 g003
Polymers 17 00484 g004
Figure 4. Antibacterial activity of CS, CS/3T, and CS/3T/C sutures against S. aureus at different time intervals (A), curcumin release profile of CS/3T/C suture sample (B), EDS spectra of the CS/3T/C suture after 3-day incubation in SBF (C), EDS spectra of the CS/3T/C suture after 14-day incubation in SBF (D), and FTIR spectra of the CS/3T/C suture after 3 and 14 days’ incubation in SBF (E).
Figure 4. Antibacterial activity of CS, CS/3T, and CS/3T/C sutures against S. aureus at different time intervals (A), curcumin release profile of CS/3T/C suture sample (B), EDS spectra of the CS/3T/C suture after 3-day incubation in SBF (C), EDS spectra of the CS/3T/C suture after 14-day incubation in SBF (D), and FTIR spectra of the CS/3T/C suture after 3 and 14 days’ incubation in SBF (E).
Polymers 17 00484 g004
Table 1. Composition of the spinning solutions of the produced sutures.
Table 1. Composition of the spinning solutions of the produced sutures.
Sample CodeChitosan (g)TiO2 (g)Curcumin (g)
CS0.80000
CS/1T0.7920.0080
CS/3T0.7760.0240
CS/5T0.7600.0400
CS/3T/C0.7680.0240.008
Table 2. Mechanical properties of the produced sutures.
Table 2. Mechanical properties of the produced sutures.
SampleBreaking Strength (N)Tensile Strength (MPa)Elongation at Break (%)
CS0.74 ± 0.02168.63 ± 5.172.55 ± 0.18
CS/1T0.77 ± 0.05176.17 ± 12.232.63 ± 0.52
CS/3T0.84 ± 0.04189.41 ± 8.213.37 ± 0.49
CS/5T0.66 ± 0.02148.83 ± 5.392.77 ± 0.30
CS/3T/C0.57 ± 0.01128.10 ± 2.672.5 ± 0.01
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Demirci, F. Development of Curcumin-Loaded TiO2-Reinforced Chitosan Monofilaments for Biocompatible Surgical Sutures. Polymers 2025, 17, 484. https://doi.org/10.3390/polym17040484

AMA Style

Demirci F. Development of Curcumin-Loaded TiO2-Reinforced Chitosan Monofilaments for Biocompatible Surgical Sutures. Polymers. 2025; 17(4):484. https://doi.org/10.3390/polym17040484

Chicago/Turabian Style

Demirci, Fatma. 2025. "Development of Curcumin-Loaded TiO2-Reinforced Chitosan Monofilaments for Biocompatible Surgical Sutures" Polymers 17, no. 4: 484. https://doi.org/10.3390/polym17040484

APA Style

Demirci, F. (2025). Development of Curcumin-Loaded TiO2-Reinforced Chitosan Monofilaments for Biocompatible Surgical Sutures. Polymers, 17(4), 484. https://doi.org/10.3390/polym17040484

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop